Rallybio Expands Leadership Team and Strengthens Drug Acquisition Capabilities

FARMINGTON, Conn.--(BUSINESS WIRE)-- #Rallybio--Rallybio LLC, a development-stage biotechnology company, today announced that it has further expanded its drug acquisition and development capabilities with the addition of Amanda Hayward, PhD and Lisa Sinclair, to the Rallybio team. Specifically, Dr. Hayward will focus on further building Rallybio’s portfolio and Ms. Sinclair will be focused on new product commercial planning including diagnostic and patient access approaches to support the portfolio. These

Click to view original post

Rallybio Expands Leadership Team and Strengthens Drug Acquisition Capabilities

FARMINGTON, Conn.--(BUSINESS WIRE)-- #Rallybio--Rallybio LLC, a development-stage biotechnology company, today announced that it has further expanded its drug acquisition and development capabilities with the addition of Amanda Hayward, PhD and Lisa Sinclair, to the Rallybio team. Specifically, Dr. Hayward will focus on further building Rallybio’s portfolio and Ms. Sinclair will be focused on new product commercial planning including diagnostic and patient access approaches to support the portfolio. These

Click to view original post